Workflow
Dividend King
icon
Search documents
The Motley Fool Just Ranked the Biggest Consumer Staples Stocks. Here's Why the No.
The Motley Fool· 2025-08-24 15:38
Core Viewpoint - PepsiCo is highlighted as a potentially "recession-proof" investment opportunity due to its strong business model and history of dividend increases, despite current challenges affecting its stock price [2][7]. Company Overview - PepsiCo is a leading player in the consumer staples sector, focusing on food and beverages, with well-known brands like Pepsi, Frito-Lay, and Quaker Oats [5]. - The company has a market capitalization of approximately $200 billion, providing it with the ability to consolidate promising brands and adapt to consumer preferences [5]. Business Model Strength - PepsiCo's business model is characterized by its resilience during economic downturns, as consumer staples are essential items that maintain steady demand [3]. - The company has a strong dividend history, being classified as a Dividend King with over five decades of annual dividend increases, indicating reliable execution and a solid business model [6]. Current Challenges - Despite its strengths, PepsiCo is currently facing challenges, with its stock price down over 20% from its 2023 highs, placing it in a personal bear market [9]. - The company's dividend yield has increased to 3.8%, providing an attractive income stream for investors during uncertain economic times [8]. Investment Considerations - Investing in PepsiCo may be beneficial during a recession, as consumer staples are viewed as safe haven stocks, potentially leading to better stock performance even in a bear market [10]. - Recent acquisitions, including a Mexican-American food maker and a pre-biotic beverage company, suggest that PepsiCo is returning to strategies that have historically driven long-term growth [12].
2 Dirt-Cheap Stocks to Buy With $1,000 Right Now
The Motley Fool· 2025-08-23 09:10
Even with markets flirting with record highs, the market continues to offer compelling bargains.In today's market environment, all three of the major indexes have either set or come close to reaching record highs. While that points to bullish conditions for shareholders, it also increases the odds that the market has become pricey, presumably leaving investors with few options to find cheap stocks.Fortunately for bargain hunters, one can still find stocks trading at reasonable valuations. Such conditions ar ...
Lowe's Builds Value for Investors: Still a Good Buy in 2025
MarketBeat· 2025-08-20 23:13
Core Insights - Lowe's Companies demonstrates strong performance with a beat-and-raise quarter, improved profitability, and strategic acquisitions aimed at expanding its Pro market presence and enhancing its position in the new home market [1][2] Financial Performance - The company reported a dividend yield of 1.87% and an annual dividend of $4.80, maintaining a dividend increase track record of 53 years [6][7] - The P/E ratio stands at 21.31, with a price target of $271.68, indicating a potential upside of 5.61% from the current price of $257.24 [11] Market Position and Growth Outlook - Despite macroeconomic challenges, Lowe's is positioned for future growth, particularly with an anticipated rebound in the housing market driven by demand in DIY and Pro segments [2] - Analysts forecast revenue and earnings growth to accelerate to high single-digits over the next few years, supported by recent acquisitions [12] Shareholder Value and Capital Management - The company has a strong balance sheet, with a 17% reduction in deficit and declining net leverage, allowing for continued investment in shareholder value [10] - Share repurchases have reduced the share count by over 25% in the last five years, contributing to upward price action [9] Stock Performance and Market Sentiment - Lowe's stock price has shown volatility, crossing critical resistance points but facing potential pullbacks within its trading range [13] - The guidance for the remainder of the year is optimistic, although it may lead to stock price fluctuations in the near term [11]
Thirsty for Passive Income? PepsiCo's Dividend Yield Continues to Deliver.
The Motley Fool· 2025-08-10 22:00
Core Viewpoint - PepsiCo presents a strong opportunity for dividend-focused investors despite current challenges, as its long-term performance and dividend history suggest potential for recovery and growth [1][9][10]. Company Overview - PepsiCo is a leading global beverage and snack company, recognized for its diversified portfolio, including its flagship beverage brand, Frito-Lay snacks, and Quaker Oats [4][5]. - The company has a robust distribution system and a strong R&D team, allowing it to compete effectively with peers and act as an industry consolidator [5]. Current Financial Performance - PepsiCo's organic sales growth of 2.1% in Q2 2025 is significantly lower than Coca-Cola's 5%, indicating current struggles relative to competitors [6]. - The stock has declined over 25% from its 2023 highs, resulting in a historically high dividend yield of approximately 4% [7][9]. Investment Opportunity - The significant drop in stock price may present a buying opportunity for long-term investors, as the company's valuation metrics are below their five-year averages [9]. - PepsiCo's status as a Dividend King, with over five decades of annual dividend increases, reflects its ability to navigate challenging periods successfully [10]. Management Confidence - Despite current headwinds, PepsiCo's board approved a 5% dividend increase in June 2025, indicating management's confidence in the company's future prospects [11]. - Recent acquisitions, including a Mexican-American food maker and a probiotic beverage company, are part of efforts to modernize the brand portfolio and address short-term challenges [12].
1 Magnificent S&P 500 Dividend Stock Down 4% to Buy and Hold Forever
The Motley Fool· 2025-08-03 09:12
Core Viewpoint - Coca-Cola's recent stock price decline presents a buying opportunity for dividend-seeking investors despite the overall market rebound [1][12] Financial Performance - Coca-Cola's revenue grew by 5% year-over-year when excluding foreign-currency translation effects and acquisitions/divestitures, driven by higher prices and a favorable product mix [6] - Adjusted operating income increased by 15% year-over-year, indicating profitability even in a challenging quarter [6] - The company experienced a drop in volume during the second quarter, which disappointed investors [5] Dividend Information - Coca-Cola raised its quarterly dividend payout by more than 5% to $0.51, marking 63 consecutive years of dividend increases, qualifying it as a Dividend King [9] - The company maintains a payout ratio of 69%, suggesting it can comfortably sustain its dividend payments [10] - Coca-Cola's dividend yield stands at 3%, significantly higher than the S&P 500's yield of 1.2% [10] Valuation Metrics - The recent decline in Coca-Cola's share price has improved its valuation, with a current price-to-earnings (P/E) ratio of 24, down from 29 [11] - Compared to the S&P 500, which has a P/E ratio of 30, Coca-Cola offers a more attractive valuation [11] - The company's long-term growth targets are 4% to 6% annual revenue growth and 7% to 9% earnings per share increases [11]
3 Dividend Champion Stocks I'm Watching in 2025
The Motley Fool· 2025-08-02 09:41
Dividend Champions Overview - A company must increase its dividend for at least 25 consecutive years to be classified as a Dividend Champion, with nearly 140 stocks currently meeting this criterion [1] AbbVie - AbbVie is a Dividend King, having increased its dividend for 53 consecutive years, with a current yield of 3.39% [3] - Potential tariffs on pharmaceutical imports to the U.S. could impact AbbVie, but analysts believe it may be less affected than peers due to its domestic manufacturing capacity [4] - AbbVie reported strong second-quarter results, with expectations that its drugs Skyrizi and Rinvoq will generate combined sales exceeding the peak annual sales of Humira [5] Chevron - Chevron is a Dividend Champion with 38 consecutive years of dividend increases and a forward yield of 4.5% [6] - The recent acquisition of Hess is a key focus, with integration expected to have a delayed impact on stock performance [7] - Oil prices have declined this year, but Chevron's shares have remained stable; any potential sell-off could present a buying opportunity for long-term investors [8] Target - Target is also a Dividend King, having increased its payout for 54 consecutive years, with a forward dividend yield of 4.5% [9] - The company is facing challenges, including declining consumer confidence and backlash over diversity initiatives, but continues to generate solid profits [10] - Target's stock is attractively valued after recent sell-offs, with a forward price-to-earnings ratio of 14.2 [11]
AbbVie Stock Eyes Breakout as Pipeline and Profits Grow
MarketBeat· 2025-07-31 17:23
Core Viewpoint - AbbVie Inc. reported strong second-quarter 2025 earnings, exceeding revenue and EPS expectations, which has positively impacted its stock price [1][6]. Financial Performance - AbbVie achieved global net revenue of $15.42 billion, surpassing the expected $14.93 billion [1]. - The earnings per share (EPS) was reported at $2.97, exceeding the forecast of $2.91 by 2% [1]. - Humira's net revenues were $1.18 billion, reflecting a year-over-year decline of 58.1% [5]. - Skyrizi generated net revenues of $4.42 billion, a 61.8% increase year-over-year, while Rinvoq reported $2.02 billion, a 41.8% increase [5]. - The overall immunology portfolio contributed $7.63 billion to global net revenues, accounting for nearly 50% of the total quarterly revenue, which was up 6.8% year-over-year [5]. Guidance and Outlook - AbbVie raised its full-year EPS guidance to a range of $11.88 to $12.08, higher than the previous guidance of $11.67 to $11.87 [6]. - The company’s positive outlook comes despite potential impacts from a new 15% tariff on EU-produced pharmaceuticals entering the U.S. [7]. Stock Performance and Analyst Ratings - AbbVie stock is currently priced at $195.40, with a 12-month price target of $211.29, indicating an 8.80% upside [2][8]. - The stock has a moderate buy rating among analysts, with a consensus price target that may increase following the strong earnings report [12][13]. Strategic Moves - AbbVie is actively pursuing growth through acquisitions, including a $2.1 billion acquisition of Capstan Therapeutics, which will enhance its immunology pipeline [9][10]. - The company is also in talks to acquire Gilgamesh Pharmaceuticals for around $1 billion, focusing on next-generation psychedelic treatments [11].
Worried About a Bear Market? 3 Reasons to Buy PepsiCo Like There's No Tomorrow
The Motley Fool· 2025-07-27 01:05
Group 1: Company Overview - PepsiCo announced stronger-than-expected second-quarter 2025 earnings, leading to a 6% stock price increase, although the stock remains over 20% down from its 2023 highs [1][8] - The company is a major player in the consumer staples sector, producing beverages, salty snacks, and packaged foods, with iconic brands like Pepsi, Frito-Lay, and Quaker Oats [2] - PepsiCo's size, distribution strength, and brand loyalty contribute to its resilience during economic downturns, making it a safe haven for investors [4] Group 2: Market Position - PepsiCo is currently in its own bear market, with stock performance lagging behind peers like Coca-Cola [7] - Despite the recent earnings boost, the stock's significant decline suggests it may not suffer as much as the broader market in a downturn [8][9] - The company is taking steps to improve its performance, including cost-cutting measures and acquiring relevant brands [12] Group 3: Investment Considerations - PepsiCo is recognized as a Dividend King, having increased its dividends for over five decades, indicating its ability to withstand economic challenges [10] - The stock offers a historically high dividend yield of around 4%, providing a reliable income stream for investors during market downturns [11] - Given the combination of a reliable business model, attractive dividend yield, and current stock price decline, PepsiCo appears to be a viable investment option even for those not specifically concerned about a bear market [13]
Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield
MarketBeat· 2025-07-18 16:34
Core Viewpoint - Abbott Laboratories is positioned as a strong investment opportunity for Q2 2025, supported by its management, portfolio, cash flow, capital return, and pipeline despite recent stock price pressure due to Q3 guidance not exceeding market expectations [1][11]. Financial Performance - The company reported a revenue growth of 7.4%, exceeding expectations by approximately 70 basis points, with organic growth at 6.9% and 7.5% excluding COVID-19 testing supplies [7]. - Adjusted earnings reached $1.26, reflecting a 10.5% increase compared to a slower 7.4% top-line growth, aided by improved adjusted gross and operating margins [9][10]. Capital Return and Shareholder Value - Abbott's dividend yield stands at approximately 1.8%, with a payout that has grown at a robust 10% CAGR over the past few years, showcasing its status as a Dividend King with over 50 years of increased payouts [5]. - The company is actively reducing its share count through share repurchases, which is expected to continue through the end of the year, enhancing shareholder value [6][3]. Market Outlook and Analyst Sentiment - Analysts have a 12-month stock price forecast for Abbott Laboratories at $144.79, indicating a potential upside of 15.77%, with a consensus rating of Moderate Buy [8][12]. - The stock is experiencing a bullish sentiment among analysts, with a steady stream of upgrades and price target revisions, suggesting a positive outlook for the company's stock price [12][13]. Guidance and Future Prospects - The company has narrowed its revenue growth guidance to a solid range of 7.5% to 8%, with earnings aligning with consensus figures, although a stronger catalyst is needed for significant share price increases [11]. - Abbott's pipeline shows advancement in key studies and a major approval, which supports the long-term growth trajectory and cash flow sustainability [10][11].
Is Coca-Cola (KO) stock a buy after Trump's announcement?
Finbold· 2025-07-17 10:40
Core Viewpoint - President Donald Trump announced that Coca-Cola has agreed to use cane sugar in its U.S. beverages, which is seen as a positive move for the company [1]. Company Performance - Coca-Cola's stock (KO) remained stable following the announcement, trading at $69.27, up 0.14% in pre-market [2]. - The company serves approximately 600 million consumers across 31 countries and reported a 6% organic sales growth in Q1 2025, outperforming Pepsi's 1.2% increase [4]. - Coca-Cola has a long history of annual dividend increases, exceeding 60 years, with a current yield of 2.80%, which is on the low end of its historical range [5]. - Berkshire Hathaway holds about 400 million shares of Coca-Cola, earning $816 million annually in dividends [5]. Industry Reaction - The announcement led to a decline in shares of Archer Daniels Midland and Ingredion, which dropped 6.3% and 8.9% respectively in after-hours trading [6]. - The Corn Refiners Association expressed concerns that replacing high fructose corn syrup with cane sugar could negatively impact American food manufacturing jobs and farm income, while providing no nutritional benefits [7]. - The market remains uncertain as further official updates and confirmations are awaited from all parties involved [8].